Application
Western blot analysis of AGPAT4 Antibody (Center) in MDA-MB435 cell line lysates (35ug/lane). AGPAT4 (arrow) was detected using the purified Pab.Application
AGPAT4 Antibody (Center) flow cytometry analysis of MDA-MB231 cells (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | AGPAT4 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | AGPAT4 1-acyl-sn-glycerol-3-phosphate acyltransferase delta 1-acylglycerol-3-phosphate O-acyltransferase 4 Lysophosphatidic acid acyltransferase delta |
|---|---|
| Molecular Weight(MW) | 44021 Da |
| Function | Converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone (By similarity) |
| Tissue Specificity | Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus |
| Cellular Localization | Membrane; Multi-pass membrane protein (Potential) |
| Entrez Gene | 56895 |
|---|
Application
Western blot analysis of AGPAT4 Antibody (Center) in MDA-MB435 cell line lysates (35ug/lane). AGPAT4 (arrow) was detected using the purified Pab.
Application
AGPAT4 Antibody (Center) flow cytometry analysis of MDA-MB231 cells (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
